Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Monogalactosyldiacylglyceride and its preparation method and use

A technology of lactosyl diacylglycerol and its use, which is applied in the field of preparation of monogalactosyl diacylglyceride

Active Publication Date: 2021-04-20
OCEAN UNIV OF CHINA
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

At present, there is no literature report on the use of MGDG as a PPARα agonist, especially a dual agonist of PPARα / γ

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Monogalactosyldiacylglyceride and its preparation method and use
  • Monogalactosyldiacylglyceride and its preparation method and use
  • Monogalactosyldiacylglyceride and its preparation method and use

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0033] Example 1: Extraction preparation and structural identification of monogalactosyldiacylglyceride

[0034] Take 2000g of Hijiki, extract with 10 times the volume of 75% ethanol under reflux for 2h, repeat 3 times. Combine the extracts, filter and concentrate until there is no alcohol smell, extract 3 times with an equal volume of ethyl acetate, combine the extracts, concentrate to obtain 33.26 g of extract. The extract was dissolved in ethyl acetate, mixed with 41g 200-300 mesh silica gel H, and subjected to silica gel column chromatography, using dichloromethane-methanol as a solvent for gradient elution, wherein dichloromethane-methanol (v / v 95:5 ) to elute the resulting components, and then through Sephadex LH-20 gel column chromatography (dichloromethane-methanol 1:1) and silica gel column chromatography to obtain a mixture of monogalactosyl diacylglycerides (MGDG) , measure its 1 H-NMR spectrum and 13 C-NMR spectrum (such as figure 1 and 2 shown).

[0035] accor...

Embodiment 2

[0039] Example 2: Activation of PPARα and PPARγ by MGDG

[0040] Transcriptional activation of PPARα and PPARγ was detected using a dual-luciferase reporter gene assay. 293T cells were inoculated in 96-well plates with DMEM medium (10% FBS, without antibiotics). After 8-12 hours, the cells grew to about 60%. Without changing the medium, the plasmid was directly transfected according to the instructions of lipo2000. The total amount of plasmid was 0.075 g / well (0.05 μg PPRE, 0.005 μg internal control pRL-TK and 0.02 μg PPARα / γ). The amount of lipo2000 used was 2.5 times the mass of the transfected plasmid (2.5*0.075L=0.1875 μL / well). The plasmid and lipo2000 were mixed in 25 μL / well optim medium in advance. After 12 hours of transfection, the positive drug (the positive drug for PPARγ is rosiglitazone at a concentration of 1 μM, and the positive drug for PPARα is WY14643 at a concentration of 10 μM) and the MGDG obtained in Example 1 were added. 24 hours after adding the dru...

Embodiment 3

[0041] Example 3: Activation of MD1-MD6 on PPARα and PPARγ

[0042] The transcriptional activation of PPARα and PPARγ was detected by dual-luciferase reporter gene analysis technology, and the specific method was the same as that in Example 2. The drugs added are MD1-MD6 prepared in Example 1. The results are shown in Table 2.

[0043] Table 2 Activation of PPARα / γ by MD1~MD6

[0044]

[0045]

[0046] Note: Compared with the blank group, "*"P<0.05; "**"P<0.01; "***"P<0.001.

[0047] The results showed that the above compounds could activate PPARα and / or PPARγ to varying degrees. In particular, MD5 (compound of formula (II)) exhibited significant PPARα / γ dual agonism.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a monogalactosyldiacylglyceride having a structure as shown in formula (I), a preparation method thereof and a method for preparing PPAR α Agonists and PPARs α / γ Use of dual agonists. (I) Among them: R 1 and R 2 Represents an acyl segment, the acyl segment is a straight-chain or branched fatty acid containing 1-30 carbon atoms; and the acyl segment contains 0-15 cis or trans double bonds. The present invention discovers monogalactosyl diacylglyceride for the first time to PPAR α Agonism and PPAR α / γ The dual agonistic effect reveals the application value of this type of compound in the prevention and treatment of PPARs-related diseases. In addition, the present invention discovers and separates active components of seaweed that are beneficial to cardiovascular health, and provides medicinal substances and functional factors for the development of seaweed medicine, health food and food.

Description

technical field [0001] The present invention relates to a preparation method and application of monogalactosyl diacylglyceride, in particular to a preparation method of monogalactosyl diacylglyceride and its use as a PPARα agonist and a PPARα / γ double agonist the use of. Background technique [0002] Peroxisome proliferator-activated receptors (PPARs for short) is a member of the nuclear receptor superfamily, including three subtypes of PPARα, PPARβ (or PPARδ) and PPARγ. After being activated by ligand, PPARs first form a heterodimer with retinoid X receptor (RXR), and then with the peroxisome proliferator response element (PPRE) upstream of the target gene promoter. Combined with transcriptional regulation of target genes to regulate important biochemical processes such as lipid metabolism, lipogenesis, insulin sensitivity, inflammatory response, cell growth and differentiation. A series of metabolic syndromes are associated with PPARs, including insulin resistance, impai...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K31/7032C07H15/06C07H1/08A61P3/06A61P3/04A61P9/12A61P1/16A61P9/10A61P13/12A61P3/10A61P9/00A61P37/06
CPCA61K31/7032A61K36/02C07H1/08C07H15/06
Inventor 刘红兵王梦雪蒋盈
Owner OCEAN UNIV OF CHINA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com